Are 503B facilities required to have recall insurance?

The FDA does not directly require 503B facilities to carry recall insurance. The 503B regulatory framework focuses on cGMP compliance, adverse event reporting under 503B(b)(5)(B), and drug supply chain security - not on insurance procurement.

However, hospital purchase contracts and GPO supplier agreements routinely require dedicated recall coverage as a condition of supplier approval. Typical limits range from $3 million to $10 million first-party, with the hospital and its affiliates named as additional insureds. The standard product is a stand-alone recall policy, not a sublimit on the products liability policy.

The practical question is what the 503B's sterile injectable revenue base requires. A recall on a sterile injectable product can drive $3 million to $10 million in execution costs (notification, retrieval, destruction, replacement manufacture, lost revenue during the recall window) plus regulatory penalties and reputational damage. The first-party recall policy is the only coverage that pays the 503B for these costs directly.